LOMM Update - same ol' stuffQuestions that need answers - in my lifetime would be great.
- $80 - $100 per share
- I see the President’s update with new syringe drawing; after 10 of the Chairman’s team trying to get the syringe to work and FDA, have they abandoned it and started over?
- I understand and believe that directors and management get stock options not shares they have not paid for in cash. In my opinion, any shares they granted themselves and not paid for in full with cash need to be cancelled.
- Is the purpose for them getting options to incentivize them to ‘earn it’ by
1 – to keep advancing share price up?
2 - to keep share dilution down?
3 – to get to market as quickly as possible?
- Since the chairman began his role 10 years ago, what has he and other directors and their management delivered to LOM and us on numbers 1 – 3? Is our share price now 70% less? Has the volume of our shares been diluted by approximately 300%?
- How does their performance on number 3 look? Ten years under the chairman to get a plastic syringe FDA approved, a syringe he told us in 2014 was finished and worked perfectly.
- Did they capitalize on the Covid opportunity?
- Should they be allowed to keep or vote shares, if any, that they didn’t pay for in cash? How much have they paid themselves in salary over the past 10 years the chairman has been there?
- After we get full disclosure of any shares not paid for, salaries, all benefits and expense accounts, we shareholders need to decide exactly what we will do about it.